Buyer Due Diligence · Video Evidence Library

On-Site Facility, QC, Packaging & Ingredient Video Briefs

Verify our Suzhou Xilin cleanroom production site, automated sterile vial filling and rotary crimping line, in-house HPLC QC inspection, 10-vial private-label kit packaging, and technical briefings for key cosmetic peptides and scalp-care actives — complete with indexed transcripts and timestamps.

Facility, Cleanroom & QC Verification

On-Site Production, Cleanroom & Analytical QC Videos

Visual due-diligence records from Suzhou Xilin Biotechnology Co., Ltd. (苏州汐霖生物科技有限公司) — WUMO Peptide’s production site — covering sterile vial filling, rotary crimping, HPLC purity inspection, Class 10,000 / 100,000 cleanroom operations, and R&D formulation laboratories.

On-Site Facility & QC0:28

Production & Analytical QC Walkthrough · 0:28

Automated Sterile Vial Filling, Rotary Crimping & HPLC QC Inspection Line

On-site walkthrough of our cleanroom corridor, automated multi-lane vial filling and rotary aluminum cap crimping turret, sterile S-curve vial conveyor track, laboratory glassware preparation, and in-house HPLC chromatogram review alongside preparative purification columns.

Verification scope:On-site cleanroom filling line, rotary vial crimping & HPLC analytical workstation
Jump to timestamp:

Key Verifiable Points & Parameters

  • Automated rotary starwheel feeding, stopper placement, and aluminum crimp sealing for glass peptide vials inside controlled cleanroom areas.
  • Continuous S-curve sterile conveyor transport of crimp-sealed vials prior to batch inspection and secondary packaging.
  • In-house QC workstation equipped with stacked analytical HPLC instrumentation, live chromatogram integration, and visual sample inspection.
  • Preparative chromatography and purification columns visible behind the analytical QC laboratory window.
Read Full Transcript & Compliance Note

Transcript & Visual Record:[00:00–00:18] Visual walkthrough: Controlled cleanroom corridor leading into the automated stainless-steel vial filling and rotary cap-crimping line. Unlabelled crimp-sealed glass vials with rubber stoppers and aluminum seals move along an S-curve conveyor track viewed through the cleanroom partition. [00:19–00:21] Laboratory technicians in protective coats, hairnets, and masks preparing laboratory glassware. [00:22–00:28] QC scientist at an analytical HPLC workstation inspecting a sample vial and recording batch notes while an HPLC chromatogram is displayed on the monitor, with preparative purification columns visible through the rear laboratory window. Spoken narration: "From our advanced production line, we extract the purest peptide."

B2B Verification & Compliance Note:Facility footage illustrates physical filling, crimping, and analytical QC equipment. Batch-specific purity, identity, sterility, and endotoxin scope must be confirmed on the quoted lot COA, HPLC, and LC-MS documentation before ordering.

Company & Production Site Documentary2:55

On-Site Documentary · Taicang, Suzhou · 2:55

Suzhou Xilin Biotechnology (苏州汐霖生物科技有限公司): R&D, Cleanroom Production & Founder Profile

Documentary profile of 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.) in Taicang Port, Suzhou — the company whose main international peptide trade website is WUMO Peptide (peptide.wumolab.com). Founder Dr. Yiqiong Ji (纪艺琼 / Dr. Kee, formerly with the Chinese Academy of Sciences) discusses 20 years of nanomedicine and transdermal active-delivery research, the 600 m² cleanroom production base, cosmetic emulsification reactors, and traceable OEM/ODM manufacturing.

Verification scope:Registered exhibitor & production entity (苏州汐霖生物科技有限公司), R&D lab & 600 m² cleanroom
Jump to timestamp:

Key Verifiable Points & Parameters

  • Entity & Location: 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.), founded in 2021 in Taicang, Suzhou, Jiangsu, China.
  • Founder & R&D Leadership: Dr. Yiqiong Ji (纪艺琼 / Dr. Kee), with 20 years of research experience in nanomedicine and transdermal active-ingredient delivery across the skin barrier.
  • Cleanroom & Equipment: 600 m² of controlled cleanroom production space, laminar flow benches, overhead formulation mixers, stainless-steel cosmetic emulsifying/homogenizing reactors, packaging lines, and warehouse dispatch.
  • Scope Boundary: Covers cosmetic formulation R&D, transdermal delivery systems, and ISO 22716 cosmetic GMP production at Suzhou Xilin.
Read Full Transcript & Compliance Note

Transcript & Visual Record:Narrator: At Taicang Port (太仓港区), an entrepreneur with a research background at the Chinese Academy of Sciences spent 20 years studying how to improve the delivery of active ingredients across the skin barrier. Then came another four years of turning that research into a real business. Title card: How many skin barriers must skincare ingredients penetrate to be fully absorbed? Dr. Yiqiong Ji (纪艺琼, Founder of 苏州汐霖生物科技有限公司 / Suzhou Xilin Biotechnology Co., Ltd.): "My name is Yiqiong Ji. I founded Suzhou Xilin Biotech in Taicang in 2021. My background is nanomedicine delivery research, essentially helping active ingredients work where they are needed. We apply this knowledge to cosmetics, improving skincare active delivery. Our facility includes 600 m² of cleanroom space, ensuring traceability. Brands choose us for our technical capabilities. For a tech-driven team, R&D, production, and market opening are challenges." Partner commentary: "Support, like a well-designed delivery system, works quietly beneath the surface. We want to be a dependable partner to growing businesses. Ms. Ji’s team remains focused on technology and approaches its work with discipline. Through professional and efficient financial services, we help them concentrate on R&D and production. This gives the company greater stability and confidence as it grows." Dr. Yiqiong Ji: "Our goal is to make advanced technology accessible, enabling brands to benefit from high-quality R&D. Quality, reliable performance, and accessible pricing are our focus. Last year, we successfully launched a cream featuring hydroxypropyl tetrahydropyrantriol (Pro-Xylane) and other products, which were well received. This year we aim to integrate new technologies and ideas for stronger product performance." Partner commentary: "Taicang Port is home to many technology-driven companies like Suzhou Xilin Biotech. They stay focused, develop their expertise, and grow steadily." Dr. Yiqiong Ji: "We are planning our layered Precision Age Care series using a layer-specific skincare approach. It combines our delivery technology with actives to address various signs of aging and skin needs. This multi-level system targets hydration, barrier care, firmness, elasticity, and smoother skin. Each formula addresses a defined concern, reflecting our core principle: precision in formulation design and active ingredient delivery." Narrator: "Research and company building take time, but with sound technology and reliable materials, their value becomes visible."

B2B Verification & Compliance Note:Note on AI English dubbing captions: The video’s burned-in English captions phonetically render 太仓 (Taicang) as "Tai Cheng / Taichung" and 汐霖 (Xilin) as "Silan / Xylan Biotech". The on-screen Chinese signage at 01:04 shows the official registered name: 苏州汐霖生物科技有限公司 (SUZHOU XILIN BIOTECHNOLOGY CO., LTD).

Lyophilized Vial & Kit Presentation

Private-Label & Multi-Vial Packaging Formats

Crimp-sealed glass peptide vial presentation, flip-off cap configuration, and 10-vial protective kit box structure for B2B private-label OEM/ODM evaluation.

Vial & Kit Packaging Format0:43

Packaging & OEM Format Showcase · 0:43

WUMO Peptide 10-Vial Presentation Kit & Crimp-Sealed Lyophilized Vial Packaging

Visual showcase of the WUMO Peptide 10-vial presentation kit box, protective black insert tray holding two rows of five crimp-sealed glass vials with white flip-off caps, applicator nozzle insert, and topical cosmetic formulation concept visuals.

Verification scope:Secondary kit box, 10-vial protective tray & crimp-sealed vial label presentation
Jump to timestamp:

Key Verifiable Points & Parameters

  • Outer Box Configuration: Rigid dark-blue textured presentation box with embossed logo and slide-open tray structure.
  • Internal Tray Layout: Custom-molded 10-vial insert (2 × 5 crimp-sealed glass vials with silver aluminum seals and white flip-off caps) plus dropper/applicator compartment.
  • OEM / Private-Label Relevance: Illustrates how vial labeling, cap/crimp color, tray layout, and outer box artwork can be coordinated for B2B private-label or cosmetic ampoule/vial kits.
  • MOQ & Project Planning: Private-label finished vial production typically starts from 1,000 vials per SKU after sample and specification sign-off.
Read Full Transcript & Compliance Note

Transcript & Visual Record:[Instrumental product showcase — no spoken voiceover] [00:00–00:08] Close-up reveal of the dark-blue textured WUMO PEPTIDE presentation box. [00:09–00:12] The presentation box opens to display 10 crimp-sealed glass peptide vials arranged in two rows of five inside a protective black insert tray, alongside a clear glass dropper/applicator nozzle and insert card. [00:13–00:15] Studio close-up of two WUMO PEPTIDE crimp-sealed glass vials with white flip-off caps. [00:16–00:37] Conceptual 3D molecular and dermal-layer animation for cosmetic skincare development. [00:38–00:43] Final studio hero view of the WUMO PEPTIDE 10-vial box beside two individual peptide vials.

B2B Verification & Compliance Note:Visuals at 00:26–00:37 depict conceptual cosmetic skincare delivery. For research-series lyophilized peptide vials, supply is strictly for qualified B2B laboratory, R&D, or manufacturing evaluation — never for personal, therapeutic, or clinical administration.

Ingredient & Formulation Technical Briefs

Cosmetic Peptide Specifications, Carrier Delivery & Reference Study Briefs

Structured technical briefings on Copper Tripeptide-1 (GHK-Cu), Acetyl Hexapeptide-8, AHPX+ chitosan carrier delivery, and Menthol Citrate Ester — covering INCI/CAS identity, solubility, formulation parameters, and supplier-reported laboratory or topical study summaries.

Cosmetic Peptide Technical Brief1:00

Ingredient & Study Brief · CAS 89030-95-5 · 1:00

GHK-Cu (Copper Tripeptide-1): Molecular Identity, HPLC/MS Checks & 56-Day Reference Formula Study

Technical overview of Copper Tripeptide-1 (GHK-Cu, CAS 89030-95-5): glycyl-L-histidyl-L-lysine copper complex structure, characteristic blue crystalline powder appearance, supplier mass spectrometry (MS) and HPLC identity/purity verification, in-vitro cell scratch migration assay, and a 56-day reference facial formula study on 36 adults.

Verification scope:INCI Copper Tripeptide-1 identity, HPLC/MS verification & reference topical study summary
Jump to timestamp:

Key Verifiable Points & Parameters

  • Identity: INCI Copper Tripeptide-1 (GHK-Cu, commonly referenced as CAS 89030-95-5, C14H22N6O4Cu) — complex of tripeptide GHK with a copper(II) ion, presenting as a characteristic blue powder.
  • Analytical Documentation: Batch identity and purity are verified through mass spectrometry (MS) and HPLC chromatographic records.
  • In-Vitro Cell Scratch Assay (Supplier Data): Tested concentrations showed +67% and +105% higher cell migration relative to control in a laboratory scratch model.
  • 56-Day Topical Reference Study (n = 36 adults): Using a 0.2% reference copper peptide facial formula twice daily for 56 days, supplier data reported -25.96% wrinkle volume and +21.65% immediate elasticity vs baseline.
Read Full Transcript & Compliance Note

Transcript & Visual Record:Meet GHK-Cu, known in cosmetics as Copper Tripeptide-1. This distinctive blue ingredient combines the tripeptide GHK with a copper ion. Supplier mass spectrum and HPLC records help document sample identity and purity. In a cell scratch assay, tested concentrations showed higher migration than control (+67% and +105% vs control). These are laboratory findings. A separate 56-day facial product study followed 36 adults using a formula with 0.2% reference copper peptide complex twice daily. At day 56, the supplier reported 25.96% lower wrinkle volume and 21.65% higher immediate elasticity versus baseline for that formula. Explore Copper Tripeptide-1 for skincare designed to improve the appearance of fine lines. For cosmetic formulation development.

B2B Verification & Compliance Note:Cell scratch and 56-day topical study figures represent supplier-reported laboratory and reference-formula data (0.2% reference copper peptide formula, n = 36) for cosmetic formulation context only. Any third-party trade names appearing in literature or reference charts remain the property of their respective owners. Confirm batch-specific COA, HPLC purity, MS identity, and copper content on your quoted WUMO batch before ordering.

Cosmetic Peptide Specification Brief0:55

Specification & Formulation Brief · CAS 616204-22-9 · 0:55

Acetyl Hexapeptide-8 (CAS 616204-22-9): Raw Material Specifications, Water Solubility & 56-Day Study

Specification and formulation walkthrough for Acetyl Hexapeptide-8 (CAS 616204-22-9, MW 889.01): aqueous dissolution demonstration, typical raw-material specification parameters (Purity ≥98.0%, Water ≤7.0%, Acetate ≤15.0%, Solubility ≥5 mg/mL in H2O), recommended formulation range (100–1,000 ppm, pH 3–8), and 56-day topical test solution study on 17 women.

Verification scope:INCI Acetyl Hexapeptide-8 specifications, aqueous solubility & 56-day topical test data
Jump to timestamp:

Key Verifiable Points & Parameters

  • Identity & Analytical Specs: INCI Acetyl Hexapeptide-8, CAS 616204-22-9, Molecular Weight 889.01 Da, Purity ≥98.0%, Water ≤7.0%, Acetate ≤15.0%, Aqueous Solubility ≥5 mg/mL (H2O).
  • Formulation Guidelines: Water-soluble white to off-white powder; suggested use level 100–1,000 ppm (0.01%–0.1%) at formulation pH 3–8; store cool and dry (-5 to 8 °C, 2-year shelf life).
  • 56-Day Topical Study (n = 17 women): Using a 0.05% (500 ppm) test solution twice daily across Day 0, 14, 28, and 56.
  • Measured Day 56 Outcomes vs Baseline: Facial line volume -21.92% and facial line area -21.51% in the supplier-recorded topical study.
Read Full Transcript & Compliance Note

Transcript & Visual Record:Meet Acetyl Hexapeptide-8, a cosmetic peptide for fine-line care. This water-soluble ingredient is designed for topical skincare formulas. Specification summary: INCI Acetyl Hexapeptide-8, CAS No. 616204-22-9, Appearance white to off-white powder, Mass spec MW 889.01, Purity ≥98.0%, Water ≤7.0%, Acetate ≤15.0%, Solubility ≥5 mg/ml (H2O), Pack size 1–500g, Storage cool and dry (-5 to 8 °C), Shelf life 2 years. The supplier suggests 100 to 1,000 parts per million, with a formulation pH between 3 and 8. In one supplier-recorded study, 17 women used a 0.05% test solution twice daily for 56 days. By day 56, measured facial line volume was 21.92% lower, and line area was 21.51% lower than baseline. Explore Acetyl Hexapeptide-8 for skincare designed to improve the appearance of fine lines. For cosmetic formulation development.

B2B Verification & Compliance Note:Note: In the first 2 seconds of the video, the automated voiceover/caption mispronounces "Acetyl Hexapeptide-8" as "Axonyl Hexapeptide-8"; the on-screen specification table at 00:06 correctly lists INCI: Acetyl Hexapeptide-8 (CAS 616204-22-9). Study figures reflect supplier-reported topical test solution data (0.05%, n = 17) for cosmetic formulation development only.

Carrier Delivery & Formulation Brief1:20

Delivery System Brief · Acetyl Hexapeptide-8 · 1:20

AHPX+ (Acetyl Hexapeptide-8 + Hydrolyzed Chitosan Carrier): Penetration & 28-Day Split-Face Study

Technical briefing on AHPX+, a cosmetic delivery system pairing Acetyl Hexapeptide-8 with a hydrolyzed chitosan carrier to enhance transdermal uptake. Reviews preclinical mouse-skin fluorescence penetration (+82% at 2 h, +219% at 8 h vs peptide alone) and a 28-day split-face study on 33 adults using a 1% AHPX+ cream (-30.4% crow’s-feet length, +17.6% R2 elasticity vs baseline).

Verification scope:Hydrolyzed chitosan peptide delivery concept, preclinical penetration & 28-day split-face data
Jump to timestamp:

Key Verifiable Points & Parameters

  • Delivery Architecture: Pairs Acetyl Hexapeptide-8 with a hydrolyzed chitosan carrier designed to improve hydrophilic peptide transport across the stratum corneum.
  • Preclinical Fluorescence Penetration (Mouse Skin Model): Carrier formula showed +82% higher relative fluorescence at 2 hours and +219% higher at 8 hours compared with Acetyl Hexapeptide-8 alone.
  • 28-Day Split-Face Study Design: 33 adult volunteers comparing a cream containing 1% AHPX+ against a comparator cream from Day 0 to Day 28.
  • Measured Day 28 Split-Face Outcomes: Crow’s-feet length decreased by 30.4% and the Cutometer R2 gross elasticity parameter increased by 17.6% vs baseline on the 1% AHPX+ side.
Read Full Transcript & Compliance Note

Transcript & Visual Record:Meet AHPX+, a cosmetic ingredient system built around Acetyl Hexapeptide-8. Computational screening helped guide peptide selection. The selected peptide is paired with a hydrolyzed chitosan carrier. In a mouse skin model, the carrier formula showed higher relative fluorescence than the peptide alone at 2 and 8 hours (+82% at 2 h and +219% at 8 h vs peptide alone; supplier-reported preclinical data). Laboratory assays also explored the peptide’s molecular interactions. The supplier then conducted a 28-day half-face study with 33 adults comparing a cream containing 1% AHPX+ with a comparator cream. At day 28, measured crow’s-feet length fell 30.4%, while the R2 elasticity parameter rose 17.6% from baseline on the AHPX+ side. Explore AHPX+ for skincare designed to improve the appearance of fine lines and firmness. For cosmetic formulation development.

B2B Verification & Compliance Note:Preclinical fluorescence penetration and 28-day split-face figures reflect supplier-reported data for the tested 1% AHPX+ carrier formulation (n = 33). Confirm whether your inquiry requires neat Acetyl Hexapeptide-8 powder (CAS 616204-22-9) or a carrier/compound formulation system when requesting specifications and samples.

Scalp Care Active Brief1:05

Scalp-Care Formulation Brief · 1:05

Menthol Citrate Ester: Amphiphilic Scalp-Care Active Dispersion & In-Vitro Study Overview

Formulation overview of Menthol Citrate Ester — a cooling scalp-care active synthesized by esterifying L-menthol with citric acid. Explains its amphiphilic dispersion in aqueous and multi-phase scalp formulas (shampoos, scalp cleansing gels, scalp sprays) and supplier in-vitro contact testing against Malassezia furfur at 1.5%–2.0%.

Verification scope:Scalp-care co-formulation active, aqueous dispersion & supplier in-vitro test summary
Jump to timestamp:

Key Verifiable Points & Parameters

  • Chemistry & Structure: Synthesized via esterification of L-menthol with citric acid, combining a cooling menthol sensory profile with an amphiphilic structure.
  • Formulation Compatibility: Disperses more readily than free menthol in water-based and multi-phase scalp systems, including shampoos, scalp cleansing gels, and leave-on scalp sprays.
  • Supplier In-Vitro Contact Data (3-Minute Contact): A tested shampoo containing 1.5% to 2.0% Menthol Citrate Ester showed 90.59% (at 1.5%) to 95.29% (at 2.0%) inhibition of Malassezia furfur in laboratory testing.
  • Scalp-Care Co-Formulation Context: Evaluated alongside scalp-care actives such as Diaminopyrimidine Oxide (Aminexil) and Copper Tripeptide-1 (GHK-Cu) in OEM/ODM hair and scalp programs.
Read Full Transcript & Compliance Note

Transcript & Visual Record:A refreshing scalp care formula starts with the right ingredient. Menthol citrate ester is made by esterifying L-menthol with citric acid. It retains a fresh menthol sensation. Its amphiphilic structure helps it disperse in water-based and multi-phase formulations. Formulators can explore it in shampoos, scalp cleansing gels, and scalp sprays. In supplier laboratory testing, a shampoo with 1.5% to 2.0% menthol citrate ester showed 90.59% to 95.29% inhibition of Malassezia furfur after 3 minutes of contact (supplier-reported in-vitro data for the tested formula). Bring a clean cooling sensation to your next scalp care concept with menthol citrate ester. For cosmetic formulation development.

B2B Verification & Compliance Note:Menthol Citrate Ester is a non-peptide cosmetic scalp-care functional ester supported in WUMO / Suzhou Xilin scalp formulation programs. In-vitro Malassezia furfur inhibition figures apply only to the supplier-tested shampoo formula under 3-minute laboratory contact conditions and do not constitute an anti-dandruff drug or medical claim.

Due-Diligence Framework

What Video Walkthroughs Verify vs. What Batch Documentation Proves

Serious B2B procurement separates visual facility/formulation evidence from lot-specific analytical release records. Use both together when qualifying a peptide supplier.

Evaluation Dimension What These Videos Show What You Should Confirm on Batch Documents
Physical facility, cleanroom & equipment existence Real cleanroom corridors, stainless-steel cosmetic emulsification reactors, rotary vial filling/crimping turrets, and analytical HPLC workstations at Suzhou Xilin (苏州汐霖生物科技有限公司). ISO 22716:2007 certificate scope (cosmetic finished goods), third-party CNAS/CMA cleanroom inspection report (600 m² Class 10,000 areas), and site address verification.
Peptide identity & chromatographic purity How sample vials are inspected at the in-house HPLC workstation and how MS/HPLC records are used in technical review. Batch-specific COA, full HPLC chromatogram with stated method/integration, and LC-MS / ESI-MS molecular weight confirmation for the quoted lot.
Lyophilized vial & private-label kit configuration Crimp-sealed glass vials, flip-off cap sealing, S-curve sterile conveyor handling, and 10-vial rigid presentation box with protective insert tray. Project-specific fill specification (mg/vial), net peptide content vs HPLC purity basis, label artwork sign-off, and sterility/endotoxin reports where applicable.
Cosmetic peptide formulation & efficacy context Aqueous solubility, recommended use levels (ppm) and pH windows, carrier delivery mechanisms (AHPX+ chitosan), and supplier-reported laboratory or topical study summaries. Raw material specification sheet, SDS/MSDS, TDS, and buyer-side stability/compatibility testing in your target base formula.

Buyer FAQ

Common Questions About Our Facility & Technical Videos

How our video evidence connects to Suzhou Xilin manufacturing, private-label OEM/ODM, and batch-level COA/HPLC/MS verification.

Where were the facility and cleanroom videos filmed?

The facility, laboratory, and cleanroom footage was filmed on-site at 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.) in Taicang, Suzhou, Jiangsu, China — WUMO Peptide’s own production site and registered Canton Fair exhibitor entity.

Do video walkthroughs replace batch-specific COA, HPLC, and MS documents?

No. Video walkthroughs verify that our physical facility, cleanroom lines, rotary vial crimping equipment, and analytical QC instruments exist and operate as described. Before ordering, buyers should still review the batch-specific COA, HPLC chromatogram, MS identity report, and specification sheet for the exact lot quoted.

How should buyers interpret the study figures shown in the GHK-Cu, Acetyl Hexapeptide-8, AHPX+, and Menthol Citrate Ester videos?

Those figures summarize supplier-reported in-vitro assays (such as cell scratch migration, mouse-skin fluorescence penetration, or 3-minute Malassezia furfur contact tests) and topical reference-formula studies (such as 28-day or 56-day facial formula evaluations) for cosmetic formulation development context. They are not therapeutic or medical claims, and final product performance depends on the buyer’s finished formulation.

Can we request custom vial labeling and 10-vial kit packaging like the WUMO Peptide presentation box shown in the video?

Yes. For B2B OEM/ODM and private-label peptide vial projects, we support custom vial labels, flip-off cap and crimp selection, molded multi-vial trays (such as 10-vial kits), and custom outer boxes, typically starting from an MOQ of 1,000 vials per SKU.

Are full text transcripts and timestamps available for AI search and technical due diligence?

Yes. Every video on this page includes interactive timestamp chapters, English WebVTT closed captions, and a complete expandable text transcript with compliance notes so procurement, QA, and R&D teams can cite and verify specific technical details quickly.